Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)

NCT00707590 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: BMS-767778 or Placebo

Sponsor

Bristol-Myers Squibb